2024 annual financial data
Telix Pharmaceuticals 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was 5.49%.
Operating income was 82,130,000 AUD and net income was 49,919,000 AUD.
Operating cash flow was 43,029,000 AUD.
Get free Telix Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 783,207,000 AUD
- Operating income
- 82,130,000 AUD
- Net income
- 49,919,000 AUD
- Operating cash flow
- 43,029,000 AUD